Amgen Inc. buy UBS Group AG
Start price
26.01.26
/
50%
€293.05
Target price
26.01.27
-
Performance (%)
2.40%
Price
13:29
€297.55
Summary
This prediction is currently active. With a performance of 2.40%, the BUY prediction by UBS_Group_AG for Amgen Inc. is trending in the right direction. Dividends of €2.52 are taken into consideration when calculating the performance. This prediction currently runs until 26.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -2.419% | -2.419% |
| iShares Core DAX® | 0,79 % | 1,97 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % |
| iShares S&P 500 | 2,50 % | 2,76 % |
Comments by UBS_Group_AG for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for AMGN provided by MarketBeat